Healthcare provider profile · identity verified

Stephen Ryan Martin, MD

Family Practice · ROCK HILL, SC · NPI 1083635825

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	501	145
Atorvastatin Calcium	Atorvastatin Calcium	470	136
Levothyroxine Sodium	Levothyroxine Sodium	328	89
Rosuvastatin Calcium	Rosuvastatin Calcium	305	92
Lisinopril	Lisinopril	280	86
Metformin Hcl Er	Metformin Hcl	277	77
Pantoprazole Sodium	Pantoprazole Sodium	231	73
Hydrochlorothiazide	Hydrochlorothiazide	211	62
Metoprolol Succinate	Metoprolol Succinate	168	52
Losartan Potassium	Losartan Potassium	167	55
Omeprazole	Omeprazole	156	50
Duloxetine Hcl	Duloxetine Hcl	151	33
Gabapentin	Gabapentin	149	44
Glimepiride	Glimepiride	143	39
Albuterol Sulfate Hfa	Albuterol Sulfate	127	41
Montelukast Sodium	Montelukast Sodium	120	37
Tizanidine Hcl	Tizanidine Hcl	119	56
Meloxicam	Meloxicam	112	53
Potassium Chloride	Potassium Chloride	107	31
Prednisone	Prednisone	105	94
Allopurinol	Allopurinol	102	31
Telmisartan	Telmisartan	102	30
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	98	27
Fluticasone Propionate	Fluticasone Propionate	94	36
Sertraline Hcl	Sertraline Hcl	93	29
Jardiance	Empagliflozin	88	18
Tamsulosin Hcl	Tamsulosin Hcl	84	28
Bupropion Xl	Bupropion Hcl	81	27
Famotidine	Famotidine	80	29
Rybelsus	Semaglutide	78	20
Pravastatin Sodium	Pravastatin Sodium	77	21
Ezetimibe	Ezetimibe	76	24
Pioglitazone Hcl	Pioglitazone Hcl	76	21
Metformin Hcl	Metformin Hcl	69	21
Tramadol Hcl	Tramadol Hcl	69	22
Fluoxetine Hcl	Fluoxetine Hcl	68	20
Simvastatin	Simvastatin	67	24
Zolpidem Tartrate	Zolpidem Tartrate	66	18
Mirtazapine	Mirtazapine	59	18
Alendronate Sodium	Alendronate Sodium	54	17
Benazepril Hcl	Benazepril Hcl	54	17
Synthroid	Levothyroxine Sodium	53	12
Cephalexin	Cephalexin	52	46
Metoprolol Tartrate	Metoprolol Tartrate	51	17
Ramipril	Ramipril	47	12
Eliquis	Apixaban	46	13
Ozempic	Semaglutide	46	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Furosemide	Furosemide	43	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Mounjaro	Tirzepatide	39	suppressed
Celecoxib	Celecoxib	36	suppressed
Trazodone Hcl	Trazodone Hcl	36	13
Carvedilol	Carvedilol	35	14
Clorazepate Dipotassium	Clorazepate Dipotassium	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	12
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	11
Doxycycline Hyclate	Doxycycline Hyclate	28	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	14
Spironolactone	Spironolactone	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	12
Methocarbamol	Methocarbamol	25	11
Nifedipine Er	Nifedipine	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	22
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Valsartan	Valsartan	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	17
Lorazepam	Lorazepam	19	suppressed
Colchicine	Colchicine	18	suppressed
Temazepam	Temazepam	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Atenolol	Atenolol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Fluconazole	Fluconazole	13	12
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error